NCT02709239View on ClinicalTrials.gov

Prenatal DHA and Neurofunctional Development

NACompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

June 1, 2016

Primary Completion Date

August 20, 2020

Study Completion Date

August 16, 2021

Conditions
Use and Dose of Prenatal DHA Supplementation
Interventions
DIETARY_SUPPLEMENT

DHA 200mg

4 50mg capsules of DHA to be taken by mouth daily

DIETARY_SUPPLEMENT

DHA 800mg

4 200mg capsules of DHA to be taken by mouth daily

Trial Locations (1)

66160

University of Kansas Medical Center, Kansas City

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

University of Kansas Medical Center

OTHER

NCT02709239 - Prenatal DHA and Neurofunctional Development | Biotech Hunter | Biotech Hunter